Previously, we were the first to demonstrate the ability of LA-12 to enhance TRAIL-induced apoptosis [25], which is so far the only publication referring to the effects of the combined action of the two drugs in prostate cancer cells. Here, TNFSF10 is linked to prostate carcinoma.